During the past decade, HCCA Clinical Research Solutions conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HCCA Clinical Research Solutions" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Evoke Pharma" with 3 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "AOBiome LLC" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HCCA Clinical Research Solutions" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "HCCA Clinical Research Solutions" are "Chronic Idiopathic Constipation" (3 trials), "Diabetic Gastroparesis" (3 trials), "Severe Hypertriglyceridemia" (2 trials), "Atopic Dermatitis" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "HCCA Clinical Research Solutions" in a lesser frequency.

Most popular intervention types in "HCCA Clinical Research Solutions" are "Drug" (16 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "AC2993" (3 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Metoclopramide Nasal Spray" (2 trials). Other intervention names were less common.

The vast majority of trials in "HCCA Clinical Research Solutions" are 15 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "HCCA Clinical Research Solutions". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in HCCA Clinical Research Solutions, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HCCA Clinical Research Solutions, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".